2.015
Finanzdaten der Moleculin Biotech Inc-Aktie (MBRX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
|
|
3.25%
5.906
|
5.72 | 5.943 | 6.643 | 7.135 |
| Operating Income/Loss |
3.25%
-5.906
|
-5.72 | -5.943 | -6.643 | -7.135 |
| Income/Loss From Continuing Operations Before Tax |
42.62%
-25.40
|
-17.81 | -5.904 | -1.882 | -10.59 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
42.62%
-25.40
|
-17.81 | -5.904 | -1.882 | -10.59 |
|
|
42.62%
-25.40
|
-17.81 | -5.904 | -1.882 | -10.59 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
140.26%
37.30
|
15.53 | 9.3438 | 0.5322 | 3.7143 |
| Basic Earnings Per Share |
40.87%
-0.68
|
-1.15 | -0.63 | 0.51 | -2.85 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):